A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age.
- DOI
- 10.1080/23744235.2024.2410466
- Published
- 2025 Mar
- Container
- Infectious diseases (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/23744235.2024.2410466,
title = {A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age.},
author = {Susarla SK and Narang M and Khandgave PN and Patnaik L and Rajapantula V and M S and Bc R and Sahoo DP and Kanakasapapathy AK},
year = {2025},
journal = {Infectious diseases (London, England)},
doi = {10.1080/23744235.2024.2410466},
url = {https://doi.org/10.1080/23744235.2024.2410466}
}RIS
TY - JOUR TI - A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age. AU - Susarla SK AU - Narang M AU - Khandgave PN AU - Patnaik L AU - Rajapantula V AU - M S AU - Bc R AU - Sahoo DP AU - Kanakasapapathy AK PY - 2025 JO - Infectious diseases (London, England) DO - 10.1080/23744235.2024.2410466 UR - https://doi.org/10.1080/23744235.2024.2410466 ER -
APA
SK, S., M, N., PN, K., L, P., V, R., S, M., R, B., DP, S., & AK, K. (2025). A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age.. Infectious diseases (London, England). https://doi.org/10.1080/23744235.2024.2410466
Source records
- pubmed · retrieved 2026-09-26T23:38:25.121Z